{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:54:29Z","timestamp":1793040869821,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Hend Almutairi is supported by the University of Western Australia International Fee Scholarship (UIFS) and University Postgraduate Award"},{"name":"Medical Research Future Fund Next Generation Clinical Researchers Practitioner Fellowship","award":["1155669"],"award-info":[{"award-number":["1155669"]}]},{"DOI":"10.13039\/501100001801","name":"University of Western Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001801","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s40266-022-00982-7","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T01:02:42Z","timestamp":1668128562000},"page":"949-958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of Psychotropic Education with Quality of Life: A Before-After Study in Residential Aged Care Facilities"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-6943","authenticated-orcid":false,"given":"Hend","family":"Almutairi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6461-6846","authenticated-orcid":false,"given":"Andrew","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5148-0188","authenticated-orcid":false,"given":"Christopher","family":"Etherton-Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3650-0475","authenticated-orcid":false,"given":"Leon","family":"Flicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"982_CR1","unstructured":"Australian Institute of Health and Welfare. Dementia. Canberra (ACT): Australian Institute of Health and Welfare. 2020. Available at: https:\/\/www.aihw.gov.au\/reports\/australias-health\/dementia. Accessed 15 Mar 2021."},{"issue":"8","key":"982_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-019-1049-5","volume":"21","author":"LJ Bessey","year":"2019","unstructured":"Bessey LJ, Walaszek A. Management of behavioral and psychological symptoms of dementia. Curr Psychiatry Rep. 2019;21(8):1\u201311. https:\/\/doi.org\/10.1007\/s11920-019-1049-5.","journal-title":"Curr Psychiatry Rep"},{"issue":"2","key":"982_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40268-019-0272-1","volume":"19","author":"SV Phan","year":"2019","unstructured":"Phan SV, Osae S, Morgan JC, Inyang M, Fagan SC. Neuropsychiatric symptoms in dementia: considerations for pharmacotherapy in the USA. Drugs R&D. 2019;19(2):93\u2013115. https:\/\/doi.org\/10.1007\/s40268-019-0272-1.","journal-title":"Drugs R&D"},{"issue":"4","key":"982_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/1039856218766123","volume":"26","author":"SM Loi","year":"2018","unstructured":"Loi SM, Eratne D, Kelso W, Velakoulis D, Looi JC. Alzheimer disease: non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms. Australas Psychiatry. 2018;26(4):358\u201365. https:\/\/doi.org\/10.1177\/1039856218766123.","journal-title":"Australas Psychiatry"},{"issue":"Suppl 1","key":"982_CR5","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1093\/geront\/gnx167","volume":"58","author":"K Scales","year":"2018","unstructured":"Scales K, Zimmerman S, Miller SJ. Evidence-based nonpharmacological practices to address behavioral and psychological symptoms of dementia. Gerontologist. 2018;58(Suppl 1):S88\u2013102. https:\/\/doi.org\/10.1093\/geront\/gnx167.","journal-title":"Gerontologist"},{"issue":"1","key":"982_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13670-019-0269-1","volume":"8","author":"CL McDermott","year":"2019","unstructured":"McDermott CL, Gruenewald DA. Pharmacologic management of agitation in patients with dementia. Curr Geriatr Rep. 2019;8(1):1\u201311. https:\/\/doi.org\/10.1007\/s13670-019-0269-1.","journal-title":"Curr Geriatr Rep"},{"issue":"7","key":"982_CR7","doi-asserted-by":"publisher","first-page":"e0236830","DOI":"10.1371\/journal.pone.0236830","volume":"15","author":"S Ruangritchankul","year":"2020","unstructured":"Ruangritchankul S, Peel NM, Hanjani LS, Gray LC. Drug related problems in older adults living with dementia. PLoS\u00a0One. 2020;15(7):e0236830. https:\/\/doi.org\/10.1371\/journal.pone.0236830.","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"982_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-020-01634-4","volume":"20","author":"H Almutairi","year":"2020","unstructured":"Almutairi H, Stafford A, Etherton-Beer C, Flicker L. Optimisation of medications used in residential aged care facilities: a systematic review and meta-analysis of randomised controlled trials. BMC Geriatr. 2020;20(1):1\u201319. https:\/\/doi.org\/10.1186\/s12877-020-01634-4.","journal-title":"BMC Geriatr"},{"issue":"2","key":"982_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0004867418758919","volume":"53","author":"J Westbury","year":"2019","unstructured":"Westbury J, Gee P, Ling T, Kitsos A, Peterson G. More action needed: Psychotropic prescribing in Australian residential aged care. Aust N Z J Psychiatry. 2019;53(2):136\u201347. https:\/\/doi.org\/10.1177\/0004867418758919.","journal-title":"Aust N Z J Psychiatry"},{"issue":"12","key":"982_CR10","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1111\/imj.15608","volume":"51","author":"H Almutairi","year":"2021","unstructured":"Almutairi H, Stafford A, Etherton-Beer C, Flicker L. Pattern of prescription of psychotropics (antipsychotics, antidepressants and benzodiazepines) in Western Australian residential aged care facilities. IMJ. 2021;51(12):2140\u20133. https:\/\/doi.org\/10.1111\/imj.15608.","journal-title":"IMJ"},{"issue":"4","key":"982_CR11","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1177\/1471301218795792","volume":"19","author":"K Westaway","year":"2020","unstructured":"Westaway K, Sluggett J, Alderman C, Moffat A, Procter N, Roughead E. The extent of antipsychotic use in Australian residential aged care facilities and interventions shown to be effective in reducing antipsychotic use: a literature review. Dementia. 2020;19(4):1189\u2013202. https:\/\/doi.org\/10.1177\/1471301218795792.","journal-title":"Dementia"},{"key":"982_CR12","unstructured":"Commonwealth of Australia: Royal Commission into Aged Care Quality and Safety. Interim Report. Commonwealth of Australia. https:\/\/agedcare.royalcommission.gov.au\/sites\/default\/files\/2020-02\/interim-report-volume-1.pdf. Assessed 31 Oct 2019"},{"issue":"4","key":"982_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40501-020-00233-9","volume":"7","author":"LB Gerlach","year":"2020","unstructured":"Gerlach LB, Kales HC. Pharmacological management of neuropsychiatric symptoms of Dementia. Curr Treat Options Psych. 2020;7(4):489\u2013507. https:\/\/doi.org\/10.1007\/s40501-020-00233-9.","journal-title":"Curr Treat Options Psych"},{"key":"982_CR14","unstructured":"Commonwealth of Australia: Royal Commission into Aged Care Quality and Safety. Final Report. Commonwealth of Australia. Available at: https:\/\/agedcare.royalcommission.gov.au\/publications\/final-report-list-recommendations. Accessed 2 Mar 2022"},{"key":"982_CR15","volume-title":"Programme on mental health","author":"World Health Organisation","year":"1998","unstructured":"World Health Organisation. Programme on mental health. Geneva: World Health Organisation; 1998."},{"issue":"3","key":"982_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000280437","volume":"29","author":"R Wetzels","year":"2010","unstructured":"Wetzels R, Zuidema SU, de Jonghe JF, Verhey FR, Koopmans R. Determinants of quality of life in nursing home residents with dementia. Dement Geriatr Cogn Disord. 2010;29(3):189\u201397. https:\/\/doi.org\/10.1159\/000280437.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"10","key":"982_CR17","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/gps.4572","volume":"32","author":"C Ballard","year":"2017","unstructured":"Ballard C, Orrell M, Sun Y, Moniz-Cook E, Stafford J, Whitaker R, et al. Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD\u2014a factorial cluster randomised controlled trial. Int J Geriatr Psychiatry. 2017;32(10):1094\u2013103. https:\/\/doi.org\/10.1002\/gps.4572.","journal-title":"Int J Geriatr Psychiatry"},{"key":"982_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.nedt.2018.04.019","volume":"67","author":"M Bauer","year":"2018","unstructured":"Bauer M, Fetherstonhaugh D, Haesler E, Beattie E, Hill KD, Poulos CJ. The impact of nurse and care staff education on the functional ability and quality of life of people living with dementia in aged care: a systematic review. Nurse Educ Today. 2018;67:27\u201345. https:\/\/doi.org\/10.1016\/j.nedt.2018.04.019.","journal-title":"Nurse Educ Today"},{"issue":"1","key":"982_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ajag.13015","volume":"20","author":"H Almutairi","year":"2021","unstructured":"Almutairi H, Stafford A, Etherton-Beer C, Flicker L, Saunders R. Aged care staff perceptions of an online training program for responsive behaviours of residents with dementia. Austalas J Ageing. 2021;20(1):1\u201319. https:\/\/doi.org\/10.1111\/ajag.13015.","journal-title":"Austalas J Ageing."},{"key":"982_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, et al. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175\u201391. https:\/\/doi.org\/10.3758\/BF03193146.","journal-title":"Behav Res Methods"},{"key":"982_CR21","unstructured":"Dementia Training Australia. Medication Management Consultancy Australia: Dementia Training Australia. 2021. https:\/\/dta.com.au\/medication-management-consultancy\/. Accessed 12 Apr 2021"},{"key":"982_CR22","unstructured":"Commonwealth of Australia: Royal Commission into Aged Care Quality and Safety. Psychotropic medications used in Australia\u2014information for aged care. Commonwealth of Australia. https:\/\/www.agedcarequality.gov.au\/sites\/default\/files\/media\/acqsc_psychotropic_medications_v11.pdf. Accessed 8 Mar 2021."},{"key":"982_CR23","unstructured":"World Health Organisation (WHO) Collaborating Center for Drug Statistics Methodology. Anatomical Therapeutic Chemical Classification System. ATC\/DDD Index. 2021. http:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 8 Mar 2021"},{"issue":"Suppl 1","key":"982_CR24","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","volume":"42","author":"S Leucht","year":"2016","unstructured":"Leucht S, Samara M, Heres S, Davis JM. Dose equivalents for antipsychotic drugs: the DDD method. Schizophr Bull. 2016;42(Suppl 1):S90\u20134. https:\/\/doi.org\/10.1093\/schbul\/sbv167.","journal-title":"Schizophr Bull"},{"key":"982_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jad.2015.03.021","volume":"180","author":"Y Hayasaka","year":"2015","unstructured":"Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A, et al. Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. Affect Disord. 2015;180:179\u201384. https:\/\/doi.org\/10.1016\/j.jad.2015.03.021.","journal-title":"Affect Disord"},{"key":"982_CR26","unstructured":"Drug and Alcohol Services South Australia. Benzodiazepines: information for GPs. 2014. https:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/dbd6d500407749f193d6bb222b2948cf\/Benzodiazepines+-+GPs-DASSA-August2014.pdf?MOD=AJPERES. Accessed 3 Mar 2021"},{"key":"982_CR27","unstructured":"World Health Organisation (WHO) Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health. ATC\/ DDD Index. https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 3 Mar 2021"},{"issue":"4","key":"982_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00002093-200310000-00002","volume":"17","author":"L Thorgrimsen","year":"2003","unstructured":"Thorgrimsen L, Selwood A, Spector A, Royan L, de Madariaga LM, Woods R, et al. Whose quality of life is it anyway? The validity and reliability of the Quality of Life-Alzheimer\u2019s Disease (QoL-AD) scale. Alzheimer Dis Assoc Disord. 2003;17(4):201\u20138. https:\/\/doi.org\/10.1097\/00002093-200310000-00002.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"982_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12955-016-0493-8","volume":"14","author":"G Torisson","year":"2016","unstructured":"Torisson G, Stavenow L, Minthon L, Londos E. Reliability, validity and clinical correlates of the Quality of Life in Alzheimer\u2019s disease (QoL-AD) scale in medical inpatients. Health Qual Life Outcomes. 2016;14(1):90. https:\/\/doi.org\/10.1186\/s12955-016-0493-8.","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"982_CR30","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/wnl.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308\u201314. https:\/\/doi.org\/10.1212\/wnl.44.12.2308.","journal-title":"Neurology"},{"issue":"Suppl 1","key":"982_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/ageing\/25.2.113","volume":"9","author":"DW Molloy","year":"1997","unstructured":"Molloy DW, Standish TI. A guide to the standardized Mini-Mental State Examination. Int Psychogeriatr. 1997;9(Suppl 1):87\u201394. https:\/\/doi.org\/10.1093\/ageing\/25.2.113.","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"982_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/ageing\/25.2.113","volume":"25","author":"RS Bucks","year":"1996","unstructured":"Bucks RS, Ashworth D, Wilcock G, Siegfried K. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing. 1996;25(2):113\u201320. https:\/\/doi.org\/10.1093\/ageing\/25.2.113.","journal-title":"Age Ageing"},{"key":"982_CR33","unstructured":"Guideline Adaptation Committee: Clinical Practice Guidelines and Principles of Care for People with Dementia. 2016: Guideline Adaptation Committee. https:\/\/cdpc.sydney.edu.au\/wp-content\/uploads\/2019\/06\/CDPC-Dementia-Guidelines_WEB.pdf. Accessed 3 Mar 2021."},{"issue":"11","key":"982_CR34","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.jamda.2020.03.028","volume":"21","author":"E Ito","year":"2020","unstructured":"Ito E, Berge LI, Husebo BS, Nouchi R, Sandvik RK. The negative impact of psychotropic drug use on quality of life in nursing home patients at different stages of dementia: cross-sectional analyses from the COSMOS Trial. J Am Med Dir Assoc. 2020;21(11):1623\u20138. https:\/\/doi.org\/10.1016\/j.jamda.2020.03.028.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"982_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-018-0752-0","volume":"18","author":"SL Harrison","year":"2018","unstructured":"Harrison SL, Bradley C, Milte R, Liu E, O\u2019Donnell LK, Hilmer SN, et al. Psychotropic medications in older people in residential care facilities and associations with quality of life: a cross-sectional study. BMC Geriatr. 2018;18(1):1\u20138. https:\/\/doi.org\/10.1186\/s12877-018-0752-0.","journal-title":"BMC Geriatr"},{"issue":"2","key":"982_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002500","volume":"15","author":"C Ballard","year":"2018","unstructured":"Ballard C, Corbett A, Orrell M, Williams G, Moniz-Cook E, Romeo R, et al. Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: a cluster-randomised controlled trial. PLoS Med. 2018;15(2): e1002500. https:\/\/doi.org\/10.1371\/journal.pmed.1002500.","journal-title":"PLoS Med"},{"issue":"1","key":"982_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-018-1907-4","volume":"18","author":"ID Maidment","year":"2018","unstructured":"Maidment ID, Damery S, Campbell N, Seare N, Fox C, Iliffe S, et al. Medication review plus person-centred care: a feasibility study of a pharmacy-health psychology dual intervention to improve care for people living with dementia. BMC Psychiatry. 2018;18(1):1\u201311. https:\/\/doi.org\/10.1186\/s12888-018-1907-4.","journal-title":"BMC Psychiatry"},{"issue":"10","key":"982_CR38","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/gps.5134","volume":"34","author":"TM Terum","year":"2019","unstructured":"Terum TM, Testad I, Rongve A, Aarsland D, Svendsboe E, Andersen JR. The association between specific neuropsychiatric disturbances in people with Alzheimer\u2019s disease and dementia with Lewy bodies and carer distress. Int J Geriatr. 2019;34(10):1421\u20133. https:\/\/doi.org\/10.1002\/gps.5134.","journal-title":"Int J Geriatr"},{"issue":"9","key":"982_CR39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/qjmed\/hcx077","volume":"110","author":"CT Chen","year":"2017","unstructured":"Chen CT, Chang C-C, Chang W-N, Tsai N-W, Huang C-C, Chang Y-T, et al. Neuropsychiatric symptoms in Alzheimer\u2019s disease: associations with caregiver burden and treatment outcomes. QJM Int J Med. 2017;110(9):565\u201370. https:\/\/doi.org\/10.1093\/qjmed\/hcx077.","journal-title":"QJM Int J Med"},{"issue":"11","key":"982_CR40","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/gps.5167","volume":"34","author":"L Aerts","year":"2019","unstructured":"Aerts L, Cations M, Harrison F, Jessop T, Shell A, Chenoweth L, et al. Why deprescribing antipsychotics in older people with dementia in long-term care is not always successful: Insights from the HALT study. Int J Geriatr Psychiatry. 2019;34(11):1572\u201381. https:\/\/doi.org\/10.1002\/gps.5167.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"9","key":"982_CR41","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1080\/13607863.2017.1348469","volume":"22","author":"CH Smeets","year":"2018","unstructured":"Smeets CH, Gerritsen DL, Zuidema SU, Teerenstra S, van der Spek K, Smalbrugge M, et al. Psychotropic drug prescription for nursing home residents with dementia: prevalence and associations with non-resident-related factors. Aging Ment Health. 2018;22(9):1244\u201352. https:\/\/doi.org\/10.1080\/13607863.2017.1348469.","journal-title":"Aging Ment Health"},{"issue":"8","key":"982_CR42","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1017\/S1041610211000421","volume":"23","author":"J Westbury","year":"2011","unstructured":"Westbury J, Tichelaar L, Peterson G, Gee P, Jackson S. A 12-month follow-up study of \u201cRedUSe\u201d: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. Int Psychogeriatr. 2011;23(8):1260\u20139. https:\/\/doi.org\/10.1017\/S1041610211000421.","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"982_CR43","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105\u201325. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8.","journal-title":"Lancet Public Health."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-022-00982-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T18:06:59Z","timestamp":1670522819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-022-00982-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1007\/s40266-022-00982-7","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"9 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hend Almutairi is supported by the University of Western Australia International Fee Scholarship (UIFS) and University Postgraduate Award (UPA). Leon Flicker is supported by a Medical Research Future Fund Next Generation Clinical Researchers Practitioner Fellowship no. 1155669. The funding sources had no role in the design of the study; collection, analysis, and interpretation of data; review or writing the manuscript; and decision to submit the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Hend Almutairi, Christopher Etherton-Beer, and Leon Flicker declare that they have no conflicts of interest. Andrew Stafford was a former Director of DTA and remains engaged with the organisation as a periodic consultant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Ethical approval was obtained from the University of Western Australia Human Research Ethics Committee prior to the commencement of the study (reference RA\/4\/20\/4792).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants, or their close family member, included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors approved the current manuscript for publication. All participants and or their family provided consent for publication of de-identified data.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated and\/or analysed during the current study are available from the corresponding author upon reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Study conception and design: HA, AS, CE, LF. Analysis and interpretation of data: HA and LF. The first draft of the manuscript was written by HA. All authors critically revised, commented on the drafts, and read and approved the final version of the manuscript and agree to be accountable for the work presented.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}